- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00641940
Girls in Transition Study: Helping Girls Enter the Teenage Years (GT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gender differences in rates of depression emerge during adolescence. Although rates of depression increase for both boys and girls during adolescence, the increase is more dramatic for girls. By late adolescence, girls are twice as likely as boys to develop depression. Because the transition to adolescence has been identified as a period of increased risk for girls, preventive interventions targeting early adolescent girls may promote resilience and prevent depression. The Girls in Transition (GT) program is a group intervention for 6th through 8th grade girls and is designed to address risk factors that are specific to girls. This study evaluates the effectiveness of the GT intervention in promoting coping strategies, preventing symptoms of depression and anxiety, and providing benefits in other outcomes related to depression, such as self-image.
Adolescents in this study will be assigned to one of two conditions: a group that will participate in the GT program in Spring 2006 (GT #1), or a waitlist control group that will participate in the GT program approximately two years later (GT #2). Students who participate in the program will attend eleven 90-minute after-school sessions led by the investigators. In the GT program, students learn cognitive-behavioral skills (such as strategies to cope with emotions and negative thinking) and problem-solving skills (such as assertiveness), and they discuss societal messages about women's appearance and roles. Adolescent participants will complete questionnaires about coping strategies, self-image, and feelings of hopelessness, depression and anxiety at five points during the study: at the beginning of the study (baseline) and at follow-ups approximately 6, 12, 16, and 24 months after baseline. In addition, students will complete an interview at baseline and then again 12 months later about experiences in which they have coped with stressful situations. Parents will complete a questionnaire about their child's life events at three assessment points (baseline and at follow-ups approximately 12 and 24 months after baseline).
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Swarthmore, Pennsylvania, United States, 19081
- Swarthmore College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female
- Student in grades 6 through 8
- Student in participating school
Exclusion Criteria:
- Male
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Girls in Transition (GT) program
|
In the 11-session after-school GT program, girls learn cognitive and behavioral skills related to intrapersonal, interpersonal, and social/contextual risk factors for depression.
Other Names:
|
Other: 2
Waitlist control
|
Participants in the waitlist control group will complete the GT program during the third year of the study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adolescents' coping strategies by self-report
Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Adolescents' depressive symptoms by self-report
Time Frame: Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline
|
Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adolescents' symptoms of anxiety by self-report
Time Frame: Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline
|
Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline
|
Adolescents' feelings of hopelessness by self-report
Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Adolescents' perceptions of their physical appearance by self-report
Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jane E. Gillham, Ph.D., Swarthmore College
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 803680
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Girls in Transition (GT) program
-
Oregon Social Learning CenterU.S. Department of EducationCompletedSchool ReadinessUnited States
-
Oregon Social Learning CenterNational Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute...Completed
-
Oregon Social Learning CenterU.S. Department of EducationCompleted
-
San Diego State UniversityNational Heart, Lung, and Blood Institute (NHLBI); Boys and Girls Clubs of...Not yet recruiting
-
University of Massachusetts, AmherstCompleted
-
Universidad de La FronteraCompletedCoronary Artery Disease | Acute Coronary SyndromeChile
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType 1 Diabetes MellitusUnited States
-
Göteborg UniversityKarolinska University Hospital; The Swedish Research Council; Sahlgrenska University... and other collaboratorsCompletedCongenital Heart DiseaseSweden
-
Rigshospitalet, DenmarkDanish Cancer Society; TRYG Foundation; The Danish Institute for Health Services... and other collaboratorsCompleted
-
Virginia Commonwealth UniversityThe Craig H. Neilsen Foundation; Hunter Holmes McGuire VA Medical CenterCompleted